These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4596671)

  • 21. Prophylactic antiparkinson drug use: II. Withdrawal after long-term maintenance therapy.
    Lavin MR; Rifkin A
    J Clin Pharmacol; 1991 Aug; 31(8):769-77. PubMed ID: 1679063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The abrupt withdrawal of antiparkinsonian drugs in mentally handicapped patients.
    Carter G
    Br J Psychiatry; 1983 Feb; 142():166-8. PubMed ID: 6132644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment of Parkinson tremors and forms of extrapyramidal tremors with methixene. A multicenter study].
    Volles E; Fredrich H
    Med Welt; 1983 Jun; 34(24):707-9. PubMed ID: 6888239
    [No Abstract]   [Full Text] [Related]  

  • 24. [A new synthetic antiparkinsonian drug, tropatepine hydrochloride in extrapyramidal syndromes induced by neuroleptics].
    Lambert A; dachary JM; Marie C; Oules J; Pagot R; Sales M; Vauterin C
    Encephale; 1976; 2(2):115-21. PubMed ID: 776591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiparkinsonian agents and fluphenazine decanoate.
    Idzorek S
    Am J Psychiatry; 1976 Jan; 133(1):80-2. PubMed ID: 1247126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients.
    Greenberg LM; Roth S
    Am J Psychiatry; 1966 Aug; 123(2):221-6. PubMed ID: 5947494
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 28. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
    Arnold G; Trenkwalder C; Schwarz J; Oertel WH
    Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949
    [No Abstract]   [Full Text] [Related]  

  • 29. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
    Claghorn JL
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1005-9. PubMed ID: 4214658
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic problems in the application of antiparkinsonian drugs in psychiatry].
    Piasecki T
    Psychiatr Pol; 1996; 30(1):137-50. PubMed ID: 8722246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse effects of antiparkinson drug withdrawal.
    Jellinek T; Gardos G; Cole JO
    Am J Psychiatry; 1981 Dec; 138(12):1567-71. PubMed ID: 6118066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorpromazine, clotiapine and thioridazine--a comparative clinical trial on Bantu psychotic patients.
    Van Wyk AJ; Marais GF
    S Afr Med J; 1971 Aug; 45(34):945-7. PubMed ID: 4939661
    [No Abstract]   [Full Text] [Related]  

  • 33. Lateral ventricular size and drug-induced Parkinsonism.
    Luchins DJ; Jackman H; Meltzer HY
    Psychiatry Res; 1983 May; 9(1):9-16. PubMed ID: 6577485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
    Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
    J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abrupt versus gradual withdrawal of antiparkinsonians.
    Weiner WJ
    Am J Psychiatry; 1982 Feb; 139(2):256-7. PubMed ID: 6119914
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II multiclinic study of elantrine in parkinsonism.
    Blonsky ER; Ericsson AD; McKinney AS; Rix A; Wang RI; Rimm AA
    Clin Pharmacol Ther; 1974 Jan; 15(1):46-50. PubMed ID: 4587106
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT; Stenson RL
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor disorders induced by neuroleptics: a proposed new classification.
    Crane GE; Naranjo ER
    Arch Gen Psychiatry; 1971 Feb; 24(2):179-84. PubMed ID: 4924291
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antiparkinsonian agents. 1. New method of objective evaluation of rigidity and tremor in Parkinson's disease].
    DERY JP; de GROOT J; LAURIN C; BARBEAU A
    Union Med Can; 1962 Aug; 91():842-7. PubMed ID: 13885642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.